Join
Live feed
·
PRReleasevia Quantisnow
Lixte Biotechnology Holdings Inc. logo

Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference

ByQuantisnow·Wall Street's wire, on your screen.
LIXT· Lixte Biotechnology Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIXT (Lixte Biotechnology Holdings Inc.) and more on Quantisnow.